PhilArchive
open access
Serum lmmunglobulin and Complement Levels in the Patients With Head and Neck Carcinoma and the Evaluation of Autoantibody Positivity Rate
Serum lmmunglobulin and Complement Levels in the Patients With Head and Neck Carcinoma and the Evaluation of Autoantibody Positivity Ratein this study, smooth muscle antibody (SMA), anti-nücleer antibody (ANA) anti- mitochondrial antibody (AMA), anti-parietal cell antibody (PA), antiglomerular basal membrane antibody (GM), serum immunglobulins and complement-C3 levels have been searched. The positivity rate of ANA (31.91 %) and SMA (38.29 %) were found high in sera of the patients with head and neck carcinoma which had been diagnosed histopathologically. But the positivity rate of AMA (4.25 %) PA (12.76 %) and GM (2.12 %) were low in the same group. ANA and SMA were detected in 1 O of 30 patients with laryngeal carcinoma; ANA were detected in 5 of 9 patients (55.5 %) and SMA were found in 4 of 9 patients (44.5 %) with nasopharyngeal carcinoma. There was no significant deviation in the levels of immunglobulins and complement-C3. The highest levels of immunoglobulins have been detected in patients with laryngeal carcinoma. Finding of high positivity rate of ANA and SMA in the patients with head and neck carcinoma showed an accordance with the other investigators' results.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma#993295
- Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)#835937
- Assessment and Prediction of Salivary Gland Function After Head and Neck Radiotherapy: A Systematic Review#378017
- Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma#1171712
- Liver Cancer and Immunotherapy in the Liquid Biopsy Era#208450
Record · ID 75743
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive